Literature DB >> 21070987

Management of stage I and II thymoma.

Frank C Detterbeck1, Alden M Parsons.   

Abstract

With a knowledgeable assessment of the clinical presentation and demographic and radiologic characteristics, most thymomas can be reliably identified preoperatively without the need for a biopsy. Surgery is the mainstay of treatment for stage I and II thymoma. The rate of complete resection is essentially 100% by open techniques, and recurrences are rare. A complete thymectomy via a sternotomy is the standard approach. Adjuvant radiotherapy after a complete resection does not appear to be of benefit. In the rare event of a recurrence, an aggressive approach should be taken with re-resection whenever possible.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21070987     DOI: 10.1016/j.thorsurg.2010.08.001

Source DB:  PubMed          Journal:  Thorac Surg Clin            Impact factor:   1.750


  20 in total

1.  Expression Patterns, Prognostic Value, and Intratumoral Heterogeneity of PD-L1 and PD-1 in Thymoma and Thymic Carcinoma.

Authors:  Dwight Owen; Benjamin Chu; Amy M Lehman; Lakshmanan Annamalai; Jennifer H Yearley; Konstantin Shilo; Gregory A Otterson
Journal:  J Thorac Oncol       Date:  2018-04-24       Impact factor: 15.609

Review 2.  Management of thymic tumors: a European perspective.

Authors:  Enrico Ruffini; Federico Venuta
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

3.  Robotic-assisted thymectomy for early-stage thymoma: a propensity-score matched analysis.

Authors:  Monica Casiraghi; Domenico Galetta; Alessandro Borri; Adele Tessitore; Rosalia Romano; Daniela Brambilla; Patrick Maisonneuve; Lorenzo Spaggiari
Journal:  J Robot Surg       Date:  2018-04-28

4.  Thymic neoplasm: a rare disease with a complex clinical presentation.

Authors:  Omar M Rashid; Anthony D Cassano; Kazuaki Takabe
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

5.  Clinicopathological analysis of 241 thymic epithelial tumors-experience in the Shanghai Chest Hospital from 1997-2004.

Authors:  Lei Zhu; Jie Zhang; Alexander Marx; Christel Weiss; Wen-Tao Fang
Journal:  J Thorac Dis       Date:  2016-04       Impact factor: 2.895

6.  Myasthenia gravis in patients with thymoma affects survival rate following extended thymectomy.

Authors:  Zhefeng Zhang; Youbin Cui; Rui Jia; Lei Xue; Huagang Liang
Journal:  Oncol Lett       Date:  2016-05-05       Impact factor: 2.967

7.  Extended resections of large thymomas: importance of en bloc thymectomy.

Authors:  José Francisco Corona-Cruz; Raúl Alejandro López-Saucedo; Laura Alejandra Ramírez-Tirado; Delia Pérez-Montiel; Josué Andrés González-Luna; Edgardo Jiménez-Fuentes; Oscar Arrieta
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

8.  Radical thymectomy versus conservative thymomectomy in the surgical treatment of thymic malignancies.

Authors:  Emanuele Voulaz; Giulia Veronesi; Maurizio Infante; Umberto Cariboni; Alberto Testori; Pierluigi Novellis; Edoardo Bottoni; Eliseo Passera; Emanuela Morenghi; Marco Alloisio
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

9.  Octreotide LAR and Prednisone as Neoadjuvant Treatment in Patients with Primary or Locally Recurrent Unresectable Thymic Tumors: A Phase II Study.

Authors:  Lukas Kirzinger; Sandra Boy; Jörg Marienhagen; Gerhard Schuierer; Reiner Neu; Michael Ried; Hans-Stefan Hofmann; Karsten Wiebe; Philipp Ströbel; Christoph May; Julia Kleylein-Sohn; Claudia Baierlein; Ulrich Bogdahn; Alexander Marx; Berthold Schalke
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

10.  Inferior Vena Cava and Renal Vein Thrombosis Associated with Thymic Carcinoma.

Authors:  Vlad Teodor Berbecar; Roxana Jurubita; Marina Paraschiv; Bogdan Obrisca; Bogdan Sorohan; Gener Ismail
Journal:  Case Rep Med       Date:  2017-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.